{{Rsnum
|rsid=7554511
|Gene=C1orf106
|Chromosome=1
|position=200908434
|Orientation=plus
|GMAF=0.1543
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=C1orf106
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 9.7 | 46.0 | 44.2
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.9 | 99.1
| YRI | 4.8 | 24.7 | 70.5
| ASW | 7.0 | 10.5 | 82.5
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 2.0 | 18.8 | 79.2
| LWK | 0.9 | 24.5 | 74.5
| MEX | 5.2 | 31.0 | 63.8
| MKK | 3.2 | 32.1 | 64.7
| TSI | 7.8 | 38.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19915572
|Trait=Ulcerative colitis
|Title=Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
|RiskAllele=
|Pval=0.000001
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PMID Auto GWAS
|PMID=21297633
|Trait=None
|Title=Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
|RiskAllele=C
|Pval=2E-13
|OR=1.1900
|ORtxt=[1.14-1.25]
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7554511
|overall_frequency_n=29
|overall_frequency_d=128
|overall_frequency=0.226562
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto GWAS
  |PMID=23128233
  |Trait=Inflammatory bowel disease
  |Title=Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
  |RiskAllele=C
  |Pval=1E-32
  |OR=1.16
  |ORtxt=[1.128-1.202]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=21102463
  |Trait=Crohn's disease
  |Title=Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
  |RiskAllele=C
  |Pval=2E-7
  |OR=1.14
  |ORtxt=[1.08-1.19]
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}